News

When stress mounts, its effects can manifest physically, potentially triggering eczema flares among other symptoms. Dr. Olivia Hsu Friedman, an...

Psoriasis, traditionally associated with middle-aged adults, is increasingly affecting children worldwide, prompting concern among parents and experts. This trend highlights...

At the World Psoriasis & Psoriatic Arthritis (IFPA) Conference in Stockholm, Sweden, AbbVie presented promising new data from a 148-week...

Afghanistan is witnessing a sharp rise in skin diseases and other health ailments following the Taliban's assumption of power in...

Recent findings from a Mendelian randomization study indicate that individuals with type 1 diabetes are significantly more likely to develop...

A study published in JAMA Dermatology has found that the calcitonin gene-related peptide (CGRP)-receptor monoclonal antibody erenumab may effectively reduce...

Key Takeaways: Guselkumab demonstrated sustained disease control in patients with active psoriatic arthritis (PsA) over 100 weeks. Between 50% and...

Patients with moderate-to-severe plaque psoriasis may achieve better long-term outcomes with deucravacitinib compared to apremilast, according to a recent post-hoc...

The U.S. Food and Drug Administration (FDA) has recently approved Zoryve (roflumilast) cream 0.15 percent for the treatment of mild...

The National Eczema Association (NEA), a leading nonprofit in eczema research, has invested over $4 million to date, funding crucial...